Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 4
1956 2
1957 1
1964 2
1965 2
1966 1
1968 1
1969 3
1970 1
1971 1
1972 2
1976 1
1978 2
1980 1
1981 1
1982 5
1983 3
1984 3
1985 4
1986 1
1987 6
1988 7
1989 5
1990 5
1991 11
1992 14
1993 22
1994 23
1995 20
1996 17
1997 21
1998 19
1999 31
2000 27
2001 31
2002 63
2003 55
2004 87
2005 107
2006 109
2007 125
2008 147
2009 169
2010 176
2011 236
2012 255
2013 304
2014 344
2015 404
2016 442
2017 495
2018 539
2019 591
2020 651
2021 753
2022 917
2023 921
2024 165

Text availability

Article attribute

Article type

Publication date

Search Results

7,482 results

Results by year

Filters applied: . Clear all
Page 1
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.
Richardson PG, Trudel S, Popat R, Mateos MV, Vangsted AJ, Ramasamy K, Martinez-Lopez J, Quach H, Orlowski RZ, Arnao M, Lonial S, Karanes C, Pawlyn C, Kim K, Oriol A, Berdeja JG, Rodríguez Otero P, Casas-Avilés I, Spirli A, Poon J, Li S, Gong J, Wong L, Lamba M, Pierce DW, Amatangelo M, Peluso T, Maciag P, Katz J, Pourdehnad M, Bahlis NJ; CC-92480-MM-001 Study Investigators. Richardson PG, et al. Among authors: gong j. N Engl J Med. 2023 Sep 14;389(11):1009-1022. doi: 10.1056/NEJMoa2303194. Epub 2023 Aug 30. N Engl J Med. 2023. PMID: 37646702 Clinical Trial.
Metformin accelerates bone fracture healing by promoting type H vessel formation through inhibition of YAP1/TAZ expression.
Ruan Z, Yin H, Wan TF, Lin ZR, Zhao SS, Long HT, Long C, Li ZH, Liu YQ, Luo H, Cheng L, Chen C, Zeng M, Lin ZY, Zhao RB, Chen CY, Wang ZX, Liu ZZ, Cao J, Wang YY, Jin L, Liu YW, Zhu GQ, Zou JT, Gong JS, Luo Y, Hu Y, Zhu Y, Xie H. Ruan Z, et al. Among authors: gong js. Bone Res. 2023 Aug 16;11(1):45. doi: 10.1038/s41413-023-00279-4. Bone Res. 2023. PMID: 37587136 Free PMC article.
COVID-19 vaccine hesitancy of older people in China.
Wang G, Yao Y, Wang Y, Gong J, Meng Q, Wang H, Wang W, Chen X, Zhao Y. Wang G, et al. Among authors: gong j. Clin Transl Med. 2023 Sep;13(9):e1397. doi: 10.1002/ctm2.1397. Clin Transl Med. 2023. PMID: 37691386 Free PMC article. No abstract available.
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
Gao X, Xu N, Li Z, Shen L, Ji K, Zheng Z, Liu D, Lou H, Bai L, Liu T, Li Y, Li Y, Fan Q, Feng M, Zhong H, Huang Y, Lou G, Wang J, Lin X, Chen Y, An R, Li C, Zhou Q, Huang X, Guo Z, Wang S, Li G, Fei J, Zhu L, Zhu H, Li X, Li F, Liao S, Min Q, Tang L, Shan F, Gong J, Gao Y, Zhou J, Lu Z, Li X, Li J, Ren H, Liu X, Yang H, Li W, Song W, Wang ZM, Li B, Xia M, Wu X, Ji J. Gao X, et al. Among authors: gong j. Lancet Oncol. 2023 Oct;24(10):1134-1146. doi: 10.1016/S1470-2045(23)00411-4. Lancet Oncol. 2023. PMID: 37797632 Clinical Trial.
The landscape of cancer research and cancer care in China.
Lu Z, Chen Y, Liu D, Jiao X, Liu C, Wang Y, Zhang Z, Jia K, Gong J, Yang Z, Shen L. Lu Z, et al. Among authors: gong j. Nat Med. 2023 Dec;29(12):3022-3032. doi: 10.1038/s41591-023-02655-3. Epub 2023 Dec 12. Nat Med. 2023. PMID: 38087112 Review.
Application of Silver Nanoparticles in Parasite Treatment.
Zhang P, Gong J, Jiang Y, Long Y, Lei W, Gao X, Guo D. Zhang P, et al. Among authors: gong j. Pharmaceutics. 2023 Jun 21;15(7):1783. doi: 10.3390/pharmaceutics15071783. Pharmaceutics. 2023. PMID: 37513969 Free PMC article. Review.
7,482 results